Skip to content

Clinical trials

Phase 1/2 Myelodysplastic Syndromes trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myelodysplastic Syndromes Phase: Phase 1/2 Country / region: United States Clear all

182 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20012
20027
20035
20044
20054
20069
20077
20087
20098
20105
20114
20125
201318
20149
20157
20169
20179
20188
20195
20209
202115
20229
20234
20254
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed89
Terminated42
Recruiting18
Active, not recruiting16
Withdrawn7
Unknown status6
Suspended4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center35
Fred Hutchinson Cancer Center9
National Cancer Institute (NCI)7
Incyte Corporation5
Washington University School of Medicine5
H. Lee Moffitt Cancer Center and Research Institute4
Bellicum Pharmaceuticals3
Masonic Cancer Center, University of Minnesota3
Memorial Sloan Kettering Cancer Center3
National Heart, Lung, and Blood Institute (NHLBI)3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myelodysplastic Syndromes182
Leukemia, Myeloid, Acute112
Leukemia59
Precursor Cell Lymphoblastic Leukemia-Lymphoma46
Leukemia, Myelomonocytic, Chronic43
Myeloproliferative Disorders32
Lymphoma, Non-Hodgkin28
Leukemia, Myelogenous, Chronic, BCR-ABL Positive27
Multiple Myeloma27
Lymphoma24

Trials

Showing 1 to 25 of 182. Each trial links to its page on Pharma Observatory.

82 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.